NCT02583984

Brief Summary

Acute lung injury (ALI) following thoracic surgery remains a major source of morbidity and mortality after lung resection. One-lung ventilation (OLV) is usually required in thoracic surgery. OLV is also an important predictor of postoperative ALI. Recent laboratory findings suggested that tissue hypoxemia and ischemia / reperfusion injury of the collapsed lungs during OLV is the major cause of lung injury. Exhaled Breath Condensate (EBC), which is the exhalate from breath typically collected by cooling device, contains most molecules found in the airway. Metabolomics refers to systematic and scientific study of chemical processes involving metabolites. This study will collect EBC for metabolomic analysis and aim to elucidate the biochemical reactions during one-lung ventilation and pathological mechanisms of acute lung injury following thoracic surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 14, 2015

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 22, 2015

Completed
1.4 years until next milestone

Study Start

First participant enrolled

March 1, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

May 25, 2016

Status Verified

May 1, 2016

Enrollment Period

1 year

First QC Date

October 14, 2015

Last Update Submit

May 24, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of participants with acute lung injury following thoracic surgery

    30 days

Secondary Outcomes (1)

  • Metabolome of exhaled breath condensate associated with lung injury in thoracic surgery

    5 hours

Study Arms (2)

Thoracic Surgery with Lung Resection

General anesthesia and lung separation Thoracic Surgery with Lung Resection, such as lobectomy, segmentectomy

Procedure: Thoracic Surgery with Lung Resection

Thoracic Surgery without Lung Resection

General anesthesia and lung separation Thoracic Surgery without Lung Resection, such as esophageal surgery, mediastinal surgery

Procedure: Thoracic Surgery without Lung Resection

Interventions

General anesthesia and lung separation Thoracic surgery with lung resection, such as lobectomy, segmentectomy

Thoracic Surgery with Lung Resection

General anesthesia and lung separation Thoracic surgery without lung resection, such as esophageal surgery, mediastinal surgery

Thoracic Surgery without Lung Resection

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Thoracic surgical patients requiring lung isolation

You may qualify if:

  • Thoracic surgical patients requiring lung isolation
  • Pulmonary resection: lobectomy, segmentectomy
  • Esophageal surgery and no pulmonary resection
  • Mediastinal surgery and no pulmonary resection

You may not qualify if:

  • Metabolic disorder
  • Metabolic syndrome
  • Diabetes
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology, National Taiwan University Hospital

Taipei, 100, Taiwan

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Exhaled breath condensate

MeSH Terms

Interventions

Thoracic Surgical Procedures

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Study Officials

  • Ya-Jung Cheng, MD, PhD

    National Taiwan University Hospital

    STUDY CHAIR

Central Study Contacts

Ya-Jung Cheng, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 14, 2015

First Posted

October 22, 2015

Study Start

March 1, 2017

Primary Completion

March 1, 2018

Study Completion

March 1, 2018

Last Updated

May 25, 2016

Record last verified: 2016-05

Locations